Short-term results of Hylan G-F 20 versus triamcinolone acetonide for knee osteoarthritis .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Intra-Articular, Single-Shot Hylan G-F 20 Hyaluronic Acid Injection Compared with Corticosteroid in Knee Osteoarthritis: A Double-Blind, Randomized Controlled Trial
J Bone Joint Surg Am. 2016 Jun 1;98(11):885-92110 patients with knee osteoarthritis were randomized to a single injection of either hyaluronic acid (Hylan G-F 20) or corticosteroid (triamcinolone acetonide). The purpose of this study was to compare pain scores and results on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) between the two groups over a 6-month follow-up. Results demonstrated significant differences in favour of the corticosteroid group compared to the hyaluronic acid group for pain scores within the first week of follow-up and WOMAC scores within the first 2 weeks of follow-up. Differences between groups at all other time points up to 6 months were not significant.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
